X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (932) 932
Publication (45) 45
Book Review (9) 9
Book Chapter (6) 6
Newsletter (6) 6
Newspaper Article (3) 3
Trade Publication Article (3) 3
Conference Proceeding (2) 2
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (502) 502
female (364) 364
male (360) 360
animals (350) 350
sodium thiosulfate (333) 333
thiosulfates - administration & dosage (291) 291
index medicus (239) 239
middle aged (203) 203
thiosulfates - therapeutic use (195) 195
adult (180) 180
cisplatin - administration & dosage (174) 174
aged (143) 143
thiosulfate (128) 128
cisplatin (123) 123
rats (123) 123
mice (119) 119
oncology (110) 110
thiosulfates - pharmacology (109) 109
cisplatin - adverse effects (98) 98
toxicity (92) 92
chemotherapy (80) 80
pharmacology & pharmacy (80) 80
antidotes - therapeutic use (75) 75
calciphylaxis (75) 75
cyanides - poisoning (72) 72
treatment outcome (71) 71
toxicology (70) 70
cancer (68) 68
dose-response relationship, drug (66) 66
thiosulfates (66) 66
time factors (66) 66
drug therapy, combination (64) 64
antidotes - administration & dosage (63) 63
antineoplastic agents - administration & dosage (59) 59
care and treatment (59) 59
ototoxicity (54) 54
otorhinolaryngology (52) 52
antineoplastic agents - adverse effects (51) 51
cyanide (51) 51
sodium (51) 51
urology & nephrology (51) 51
cisplatin - toxicity (48) 48
protection (48) 48
combined modality therapy (47) 47
health aspects (47) 47
infusions, intravenous (47) 47
research (47) 47
adolescent (46) 46
cisplatin - therapeutic use (45) 45
injections, intravenous (45) 45
antineoplastic combined chemotherapy protocols - therapeutic use (44) 44
poisoning (43) 43
calcific uremic arteriolopathy (42) 42
dosage and administration (42) 42
infusions, parenteral (42) 42
kidney - drug effects (42) 42
hydroxocobalamin (41) 41
pharmacokinetics (41) 41
calciphylaxis - drug therapy (40) 40
high-dose cisplatin (40) 40
ovarian neoplasms - drug therapy (40) 40
analysis (39) 39
cyanides (39) 39
injections, intraperitoneal (39) 39
dermatology (38) 38
infusions, intra-arterial (38) 38
drug administration schedule (37) 37
kinetics (37) 37
cisplatin - pharmacokinetics (36) 36
rats, wistar (35) 35
therapy (35) 35
disease models, animal (34) 34
surgery (34) 34
thiosulfates - adverse effects (34) 34
child (33) 33
risk factors (33) 33
antioxidants - administration & dosage (32) 32
induced hearing-loss (32) 32
antidotes (31) 31
dogs (31) 31
hydrogen sulfide (31) 31
metabolism (31) 31
administration, oral (30) 30
chelating agents - administration & dosage (30) 30
chelating agents - therapeutic use (30) 30
sulfur (30) 30
cis-diamminedichloroplatinum (29) 29
cyanides - blood (29) 29
poisoning - drug therapy (29) 29
aged, 80 and over (28) 28
antioxidants (28) 28
complications and side effects (28) 28
follow-up studies (28) 28
intoxication (28) 28
lethal dose 50 (28) 28
prevention (28) 28
vascular calcification (28) 28
carcinoma, squamous cell - drug therapy (27) 27
neurosciences (27) 27
rats, inbred strains (27) 27
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (827) 827
Japanese (53) 53
Russian (24) 24
German (17) 17
French (10) 10
Italian (6) 6
Chinese (4) 4
Polish (2) 2
Bulgarian (1) 1
Dutch (1) 1
Hungarian (1) 1
Korean (1) 1
Romanian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pharmacological Research, ISSN 1043-6618, 2008, Volume 57, Issue 2, pp. 125 - 131
The objective of this study was to explore the optimal combination of agents used along with cisplatin for protection of hepatotoxicity. Animal experiment was... 
Oxidative stress | Side effects | Hepatotoxicity | Cisplatin | Protective agents | INDUCED APOPTOSIS | PROTEIN-KINASE | SODIUM THIOSULFATE | ALPHA-TOCOPHEROL | N-ACETYLCYSTEINE | INDUCED HEARING-LOSS | protective agents | D-METHIONINE | hepatotoxicity | INDUCED OXIDATIVE STRESS | INDUCED OTOTOXICITY | side effects | PHARMACOLOGY & PHARMACY | INDUCED NEPHROTOXICITY | cisplatin | oxidative stress | Thiosulfates - therapeutic use | Zinc - administration & dosage | Glutathione - metabolism | Male | Alanine Transaminase - blood | Antineoplastic Agents - administration & dosage | Methionine - therapeutic use | Cisplatin - administration & dosage | Antineoplastic Agents - adverse effects | Acetylcysteine - therapeutic use | Acetylcysteine - administration & dosage | Drug Therapy, Combination | Taurine - therapeutic use | Chemical and Drug Induced Liver Injury - etiology | Malondialdehyde - metabolism | Chemical and Drug Induced Liver Injury - prevention & control | Fosfomycin - therapeutic use | Injections, Intraperitoneal | Methionine - administration & dosage | Zinc - therapeutic use | Selenium - therapeutic use | Antioxidants - therapeutic use | Pilot Projects | Animals | Fosfomycin - administration & dosage | Antioxidants - administration & dosage | Cisplatin - adverse effects | Thiosulfates - administration & dosage | Mice | Taurine - administration & dosage | Selenium - administration & dosage | Methionine | Glutathione | Index Medicus
Journal Article
Journal of the American College of Surgeons, ISSN 1072-7515, 2014, Volume 218, Issue 4, pp. 573 - 585
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 25, pp. 2376 - 2385
Journal Article
Journal of Medical Toxicology, ISSN 1556-9039, 9/2013, Volume 9, Issue 3, pp. 274 - 277
Severe anion gap (AG) acidosis associated with intravenous sodium thiosulfate (STS) administration has not been previously described in nondialysis chronic... 
Anion gap acidosis | GOLD MARKS | Biomedicine | Calciphylaxis | Chronic kidney disease | Pharmacology/Toxicology | Biomedicine general | Sodium thiosulfate (STS) | Thiosulfates - therapeutic use | Acidosis, Renal Tubular - chemically induced | Acidosis, Renal Tubular - complications | Thiosulfates - adverse effects | Humans | Secondary Prevention | Hospices | Treatment Refusal | Female | Calciphylaxis - therapy | Kidney Failure, Chronic - physiopathology | Severity of Illness Index | Calciphylaxis - etiology | Calciphylaxis - physiopathology | Leg | Kidney Failure, Chronic - therapy | Antioxidants - therapeutic use | Calciphylaxis - blood | Heart Arrest - prevention & control | Acidosis, Renal Tubular - therapy | Antioxidants - administration & dosage | Kidney Failure, Chronic - complications | Heart Arrest - etiology | Thiosulfates - administration & dosage | Antioxidants - adverse effects | Critical Care | Aged | Acidosis, Renal Tubular - physiopathology | Infusions, Intravenous | Antioxidants - pharmacokinetics | Heart Arrest - complications | Thiosulfates - pharmacokinetics | Heart Arrest - therapy | Renal Dialysis | Care and treatment | Dosage and administration | Diagnosis | Acidosis | Sodium thiosulfate | Patient outcomes | Pharmacology | Kidney diseases | Drug therapy | Toxicity | Metabolic disorders | Toxicology Observation
Journal Article
Journal Article
Journal Article